High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the CHARISMA trial

M. Weber; D.L. Bhatt; D.M. Brennan; Graeme Hankey; S.R. Steinhubl; S.C. Johnston; G. Montalescot; K.-H. Mak; K.A.A. Fox; D.J. Easton; E.J. Topol; C.W. Hamm

doi:10.1136/hrt.2010.210419

High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the CHARISMA trial

M. Weber, D.L. Bhatt, D.M. Brennan, Graeme Hankey, S.R. Steinhubl, S.C. Johnston, G. Montalescot, K.-H. Mak, K.A.A. Fox, D.J. Easton, E.J. Topol, C.W. Hamm

Faculty of Health and Medical Sciences

Research output: Contribution to journal › Article

12 Citations (Scopus)

Original language	English
Pages (from-to)	626-631
Journal	Heart
Volume	97
DOIs	https://doi.org/10.1136/hrt.2010.210419
Publication status	Published - 2011

Access to Document

10.1136/hrt.2010.210419

Cite this

Weber, M., Bhatt, D. L., Brennan, D. M., Hankey, G., Steinhubl, S. R., Johnston, S. C., Montalescot, G., Mak, K-H., Fox, K. A. A., Easton, D. J., Topol, E. J., & Hamm, C. W. (2011). High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the CHARISMA trial. Heart, 97, 626-631. https://doi.org/10.1136/hrt.2010.210419

Weber, M. ; Bhatt, D.L. ; Brennan, D.M. ; Hankey, Graeme ; Steinhubl, S.R. ; Johnston, S.C. ; Montalescot, G. ; Mak, K.-H. ; Fox, K.A.A. ; Easton, D.J. ; Topol, E.J. ; Hamm, C.W. / High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the CHARISMA trial. In: Heart. 2011 ; Vol. 97. pp. 626-631.

@article{ee55f9bf68db47c29d4296a8a687d701,

title = "High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the CHARISMA trial",

author = "M. Weber and D.L. Bhatt and D.M. Brennan and Graeme Hankey and S.R. Steinhubl and S.C. Johnston and G. Montalescot and K.-H. Mak and K.A.A. Fox and D.J. Easton and E.J. Topol and C.W. Hamm",

year = "2011",

doi = "10.1136/hrt.2010.210419",

language = "English",

volume = "97",

pages = "626--631",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

}

High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the CHARISMA trial. / Weber, M.; Bhatt, D.L.; Brennan, D.M.; Hankey, Graeme; Steinhubl, S.R.; Johnston, S.C.; Montalescot, G.; Mak, K.-H.; Fox, K.A.A.; Easton, D.J.; Topol, E.J.; Hamm, C.W.

In: Heart, Vol. 97, 2011, p. 626-631.

Research output: Contribution to journal › Article

TY - JOUR

T1 - High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the CHARISMA trial

AU - Weber, M.

AU - Bhatt, D.L.

AU - Brennan, D.M.

AU - Hankey, Graeme

AU - Steinhubl, S.R.

AU - Johnston, S.C.

AU - Montalescot, G.

AU - Mak, K.-H.

AU - Fox, K.A.A.

AU - Easton, D.J.

AU - Topol, E.J.

AU - Hamm, C.W.

PY - 2011

Y1 - 2011

U2 - 10.1136/hrt.2010.210419

DO - 10.1136/hrt.2010.210419

M3 - Article

C2 - 21393433

VL - 97

SP - 626

EP - 631

JO - Heart

JF - Heart

SN - 1355-6037

ER -